During the past decade, Grupo Estudios Clínicos Infectología Respiratoria conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Grupo Estudios Clínicos Infectología Respiratoria" are "Pneumococcal Disease" (1 trials) and "Respiratory Tract Infection" (1 trials). Many other conditions were trialed in "Grupo Estudios Clínicos Infectología Respiratoria" in a lesser frequency.

Most popular intervention types in "Grupo Estudios Clínicos Infectología Respiratoria" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "13-valent pneumococcal conjugate vaccine" (1 trials), "20-valent pneumococcal conjugate vaccine" (1 trials), "Placebo" (1 trials) and "RSVpreF" (1 trials). Other intervention names were less common.

The vast majority of trials in "Grupo Estudios Clínicos Infectología Respiratoria" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Grupo Estudios Clínicos Infectología Respiratoria". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Grupo Estudios Clínicos Infectología Respiratoria, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Grupo Estudios Clínicos Infectología Respiratoria, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".